Articles related to INFLUENZA

Investigators surmised that current influenza vaccination programs provide substantial protection but could be further improved by strategies that could mitigate repeat vaccination effects.

Provision of antiviral therapy does not require a positive test for influenza when influenza is circulating in the community.

Based on the data presented, the committee agreed that there was a need to change the influenza A/H3N2 virus strains from the 2024-2025 formula.

Antiviral therapy initiated within 48 hours of symptom onset can reduce illness duration by 1-2 days, highlighting the importance of early recognition and intervention in high-risk populations.

N-acetylcysteine intervention within the crucial 8-hour window provides nearly 100% effective treatment for acetaminophen overdose cases, making rapid recognition and response essential.

Guidelines from the CDC and AHA emphasize the critical role of vaccinations in protecting cardiac patients against the heightened risk of severe complications from infections like influenza and RSV, advocating for a comprehensive vaccination strategy.